Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Biofrontera AG

Start price
Target price
Perf. (%)
€0.78
04.07.23
€0.000
04.07.24
-58.31%
05.07.24

Could be very worthwhile Investment >20% year
Undervalued
kostojunior 
04.07.23 0%
buy
Bayer AG

Start price
Target price
Perf. (%)
€40.81
17.11.23
-
17.11.24
-35.72%
02.07.24

investresearch 
17.11.23 50%
sell
Medigene AG

Start price
Target price
Perf. (%)
€1.87
24.06.23
€1.00
24.06.24
-36.73%
25.06.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
geldnutzer 
24.06.23 60%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.19
27.05.24
-
27.05.25
-10.41%
23.06.24

quelbe60 
27.05.24 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.41
31.05.24
€37.00
31.05.25
-12.27%
16.06.24

Ruckelsbuckel 
31.05.24 60%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.63
29.05.24
€25.00
29.05.25
-19.77%
16.06.24

marianka1001 
29.05.24 60%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.70
03.06.24
-
03.06.25
-15.37%
12.06.24

WatchMen 
03.06.24 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€3.59
28.05.24
-
28.05.25
-30.13%
09.06.24

michaelkr 
28.05.24 50%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.76
27.05.24
-
27.05.25
-9.24%
09.06.24

Probably not worthwhile Investment
Wolf_of_WS 
27.05.24 50%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€3.62
27.05.24
-
27.05.25
-30.80%
08.06.24

Risky Investment
Global_Player 
27.05.24 50%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.05
30.05.24
-
30.05.25
22.20%
08.06.24

Could be very worthwhile Investment >20% year
daimler1 
30.05.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€28.53
07.05.24
-
07.06.24
-2.40%
08.06.24

fabudagga 
07.05.24 50%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€5.79
28.05.24
-
28.05.25
-56.74%
08.06.24

Good culture
Risky Investment
No uniques
me8 
28.05.24 0%
buy
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.70
28.05.24
-
28.05.25
-0.37%
03.06.24

bundfuture 
28.05.24 50%
buy
B.R.A.I.N. Biotechnology Research and Information Network AG

Start price
Target price
Perf. (%)
€10.10
17.06.21
€30.00
17.06.24
-71.39%
02.06.24

Maxi_Scalibusa 
17.06.21 50%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€5.44
28.05.24
-
28.05.25
-63.90%
30.05.24

Bankster 
28.05.24 50%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€2.25
24.05.24
-
24.05.25
-2.45%
25.05.24

Wolf_of_WS 
24.05.24 50%
sell
Vivoryon Therapeutics N.V.

Start price
Target price
Perf. (%)
€1.27
23.05.24
-
23.05.25
67.32%
24.05.24

Vassago1 
23.05.24 50%
sell
CytoTools AG

Start price
Target price
Perf. (%)
€1.05
01.12.23
-
01.12.24
-64.57%
13.05.24

daimler1 
01.12.23 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€17.16
10.05.23
-
10.05.24
-43.95%
11.05.24

CandyButcher 
10.05.23 50%
buy
Nanorepro AG

Start price
Target price
Perf. (%)
€2.17
09.05.23
-
09.05.24
-17.05%
10.05.24

NightTrain 
09.05.23 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.32
05.03.24
-
05.03.25
6.69%
06.05.24

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
fenjal 
05.03.24 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€26.20
17.03.24
-
17.04.24
0.50%
18.04.24

Alowa 
17.03.24 50%
buy
Evotec SE

Start price
Target price
Perf. (%)
€18.74
29.03.23
-
29.03.24
-21.64%
30.03.24

Shooter 
29.03.23 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€2.69
22.03.24
-
22.03.25
-16.73%
30.03.24

Could be very worthwhile Investment >20% year
Very capable Management
Good culture
Little innovation
me8 
22.03.24 0%